Equities

Aurora Spine Corp

ASG:CVE

Aurora Spine Corp

Actions
Health CareMedical Equipment and Services
  • Price (CAD)0.455
  • Today's Change0.02 / 4.60%
  • Shares traded4.50k
  • 1 Year change-1.09%
  • Beta0.6775
Data delayed at least 15 minutes, as of Nov 14 2024 19:57 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments0.770.423.17
Total Receivables, Net3.973.672.67
Total Inventory3.563.051.89
Prepaid expenses0.200.190.67
Other current assets, total------
Total current assets8.507.338.41
Property, plant & equipment, net2.281.911.30
Goodwill, net------
Intangibles, net0.750.880.85
Long term investments------
Note receivable - long term0.45----
Other long term assets------
Total assets121011
LIABILITIES
Accounts payable3.042.832.45
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.230.200.18
Other current liabilities, total--0.00--
Total current liabilities3.273.032.63
Total long term debt3.412.772.37
Total debt3.652.972.55
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities6.695.814.99
SHAREHOLDERS EQUITY
Common stock282525
Additional paid-in capital------
Retained earnings (accumulated deficit)(22)(21)(20)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity5.304.325.57
Total liabilities & shareholders' equity121011
Total common shares outstanding776767
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.